UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000027835
Receipt No. R000031871
Official scientific title of the study Comparison of weight loss effect of diabetes treatment for obese type 2 diabetic patients.
Date of disclosure of the study information 2017/06/26
Last modified on 2017/06/20 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Comparison of weight loss effect of diabetes treatment for obese type 2 diabetic patients.
Title of the study (Brief title) Comparison of weight loss effect of diabetes treatment for obese type 2 diabetic patients.
Region
Japan

Condition
Condition Diabetes
Classification by specialty
Medicine in general
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 By bariatric surgery on obese type 2 diabetic patients, not only weight loss effect but also metabolic improvement effect can be expected. However, bariatric surgery, which is applied for insurance in Japan, is only sleeve gastrectomy. Patients with obesity, which is an indication for surgery, are, in principle, patients with primary obesity between the ages of 18 and 65, and there is no significant weight loss and no improvement in obesity related complications despite medical treatments for more than 6 months.
Until recently, although diabetes treatment have an effect of improving blood glucose, body weight gain accompanying treatment became a problem.
GLP-1 receptor agonist and SGLT2 inhibitor are on the market. I evaluated the effect of GLP-1 receptor agonist and SGLT-2 inhibitor on obese type 2 diabetic patients on the parameters of blood glucose and BMI.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes HbA1c(0M,6M)
Key secondary outcomes BMI(0M,6M)

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 3
Purpose of intervention Treatment
Type of intervention
Medicine
Interventions/Control_1 The group treated with GLP-1 receptor agonist(Duration:6 months)
Interventions/Control_2 The group treated with SGLT-2 inhibitor(Duration:6 months)
Interventions/Control_3 The group treated with GLP-1 receptor agonist and SGLT-2 inhibitor(Duration:6 months)
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
18 years-old <=
Age-upper limit
65 years-old >=
Gender Male and Female
Key inclusion criteria BMI>=22.0
Key exclusion criteria Renal dysfunction(eGFR>=30mL/min/1.73m2)
Target sample size 60

Research contact person
Name of lead principal investigator Takahisa Hasegawa
Organization KYORITSU HOSPITAL
Division name internal medicine
Address 16-5, Chuo-cho, Kawanishi-city,Hyogo
TEL 072-758-1131
Email h.taka517@gmail.com

Public contact
Name of contact person Takahisa Hasegawa
Organization KYORITSU HOSPITAL
Division name internal medicine
Address 16-5, Chuo-cho, Kawanishi-city,Hyogo
TEL 072-758-1131
Homepage URL
Email h.taka517@gmail.com

Sponsor
Institute KYORITSU HOSPITAL
Institute
Department

Funding Source
Organization KYORITSU HOSPITAL
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 協立病院

Other administrative information
Date of disclosure of the study information
2017 Year 06 Month 26 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 03 Month 01 Day
Anticipated trial start date
2015 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 06 Month 20 Day
Last modified on
2017 Year 06 Month 20 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031871